PULIKE(SH:603566) Ge Long Hui A P P·2026-01-20 07:43Core Viewpoint - The company expects a significant increase in net profit for 2025, driven by new product launches and strategic marketing efforts [1] Financial Performance - The projected net profit attributable to the parent company for 2025 is estimated to be between 176 million to 195 million yuan, representing a year-on-year increase of 89.64% to 110.11% [1] - The expected net profit after deducting non-recurring gains and losses is forecasted to be between 137 million to 153 million yuan, reflecting a year-on-year growth of 70.19% to 90.07% [1] Business Development - The launch of new products, such as the avian adenovirus series vaccine, has contributed to the company's performance growth [1] - The pet segment has experienced rapid development through continuous efforts in channel building and brand enhancement [1] Strategic Focus - In response to intensified industry competition, price pressures, and fluctuations in downstream farming conditions, the company is focusing on marketing system reform and strengthening sales expense management [1] - The company aims to optimize production processes and procurement management to further reduce production costs, demonstrating strong operational resilience [1]